Aptevo Therapeutics, Inc. (APVO)
1.76
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.80
+0.04
(+2.27%)
Pre-Market: 08:36
Aptevo Therapeutics Market Cap : 2.497M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.497M |
| October 01, 2026 | 2.497M |
| September 30, 2026 | 2.583M |
| September 29, 2026 | 2.639M |
| September 28, 2026 | 2.710M |
| September 25, 2026 | 2.682M |
| September 24, 2026 | 2.597M |
| September 23, 2026 | 2.682M |
| September 22, 2026 | 2.625M |
| September 21, 2026 | 2.568M |
| September 18, 2026 | 2.611M |
| September 17, 2026 | 2.611M |
| September 16, 2026 | 2.441M |
| September 15, 2026 | 2.426M |
| September 14, 2026 | 2.554M |
| September 11, 2026 | 2.583M |
| September 10, 2026 | 2.597M |
| September 09, 2026 | 2.618M |
| September 08, 2026 | 2.668M |
| September 04, 2026 | 2.469M |
| September 03, 2026 | 2.426M |
| September 02, 2026 | 3.689M |
| September 01, 2026 | 3.320M |
| August 31, 2026 | 3.462M |
| August 28, 2026 | 3.356M |
| Date | Value |
|---|---|
| August 27, 2026 | 3.434M |
| August 26, 2026 | 3.420M |
| August 25, 2026 | 3.491M |
| August 24, 2026 | 3.420M |
| August 21, 2026 | 3.803M |
| August 20, 2026 | 3.916M |
| August 19, 2026 | 3.874M |
| August 18, 2026 | 4.115M |
| August 17, 2026 | 3.987M |
| August 14, 2026 | 4.172M |
| August 13, 2026 | 4.825M |
| August 12, 2026 | 4.966M |
| August 11, 2026 | 4.979M |
| August 10, 2026 | 4.839M |
| August 07, 2026 | 5.032M |
| August 06, 2026 | 4.900M |
| August 05, 2026 | 5.044M |
| August 04, 2026 | 4.924M |
| August 03, 2026 | 4.755M |
| July 31, 2026 | 4.948M |
| July 30, 2026 | 4.972M |
| July 29, 2026 | 4.791M |
| July 28, 2026 | 5.068M |
| July 27, 2026 | 5.068M |
| July 24, 2026 | 5.285M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.059B |
| Oncolytics Biotech, Inc. | 78.65M |
| Sangamo Therapeutics, Inc. | 61.11M |
| Sarepta Therapeutics, Inc. | 1.848B |
| Anixa Biosciences, Inc. | 102.02M |
Market Cap Related Metrics
| Price to Book Value | 0.4134 |
| Price | 1.76 |
| Earnings Yield | -3.28K% |